Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a clinical-stage medical device company developing a transcatheter tricuspid valve replacement system, today announced positive results from its FDA-approved U.S. Early Feasibility Study evaluating the Trisol Transcatheter Tricuspid...
DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation
WASHINGTON, Jan. 21, 2026 /PRNewswire/ -- The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural initiative, the LIFT (Linking Innovation, Funding, and Translation) Series. Together, ASCENT and LIFT create a structured, multi-stage pathway...
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines TORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research and development investment,...
New Study Reveals Organic NatureKnit® Provides Greater Prebiotic Benefits Than Purified Fibers
MOMENCE, Ill., Jan. 21, 2026 /PRNewswire/ -- New research published in Frontiers in Nutrition has revealed the significant impact of Organic NatureKnit®, an all-natural and patent-pending gut health innovation from FutureCeuticals, on the human gut microbiome. The study, conducted in partnership with ProDigest, a leading microbiome research organization based in Ghent, Belgium, demonstrates...
Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China
HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, today announced that its wholly-owned subsidiary, Sisram Medical China (Tianjin) Ltd., has entered into a memorandum of understanding ("MOU") with Sinmait...
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion Maintained momentum through consistent operational performance and robust client demand Strengthened foundation for long-term growth through expanded manufacturing readiness and operational scale INCHEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract...
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research institute focused on conducting clinical trials in hepatology and gastroenterology, with a special emphasis on metabolic liver disease. The institute delivers high-quality research that complements the...
CLEARLAB CONTACT LENSES AND LENS CARE PRODUCTS RECEIVE COMBINED MDSAP, ISO13485 AND EU MDR CERTIFICATION FROM DNV
Parallel audit streamlines certification and speeds up access to global markets SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, has certified contact lenses and multi-purpose lens care solutions from Clearlab in accordance with the Medical Device Single Audit Program (MDSAP), ISO13485 Quality Management System for...
Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for Precision Screening and Cancer Care in the U.S.
IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in validation platforms for Laboratory Developed Tests (LDTs), announced a strategic collaboration to advance U.S. verification and clinical validation of liquid biopsy assays designed for cancer detection, profiling, and monitoring. Under the agreement, Gene Solutions...
HD Partners with Pacific Prime to Pioneer AI-Native Healthcare Navigation and Hybrid Access Models in Emerging Southeast Asia
Strategic partnership expands access to hybrid healthcare models through AI-driven navigation, connecting Pacific Prime clients to HDmall, HDcare, and Jib AI across Southeast Asia. HD aims to become the AI-native healthcare front door for emerging Southeast Asia, while guiding patients to the right next step and connecting them to real-world care. BANGKOK, Jan. 21, 2026 /PRNewswire/ --...
